IOVA

IOVANCE BIOTHERAPEUTICS INC

Healthcare | Mid Cap

-$0.07

EPS Forecast

$120.8

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

-$0.07

Revenue Forecast:

$120.8

EPS Surprise Forecast:

$0.019

Revenue Surprise Forecast:

$3

Post-release price volatility - Very high

Post-release Overnight Move:

±11.3%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

65%

Probability of beating revenue consensus:

60%

Probability of beating both EPS & revs consensus:

45%

Probability of missing both EPS & revs consensus:

20%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-4

Beta (β)

Forward Looking Beta (β):

0.37

Earnings volatility

EPS standard deviation:

$0.14

Revenue standard deviation:

$33

As % of share price:

1.03% VERY HIGH

As % of market cap:

0.54% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$0.11

Revenue 95th %ile:

$164

EPS 75th %ile:

-$0.02

Revenue 75th %ile:

$133

EPS 25th %ile:

-$0.11

Revenue 25th %ile:

$111

EPS 5th %ile:

-$0.22

Revenue 5th %ile:

$85

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

39% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

74% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$13

Bid-ask per Share:

$0.015